Tyra Biosciences (TYRA) Total Current Liabilities (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Total Current Liabilities data on file, last reported at $19.3 million in Q1 2026.

• Quarterly Total Current Liabilities rose 35.17% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.3 million (up 35.17% YoY) and the FY2025 annual result came in at $18.1 million, up 23.98% from the prior year.
• Total Current Liabilities improved to $19.3 million in Q1 2026, from $18.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $19.3 million in Q1 2026 to a low of $3.7 million in Q1 2023.
• A 5-year average of $10.8 million and a median of $10.4 million in 2024 frame the typical range for Total Current Liabilities.
• The widest YoY moves for Total Current Liabilities: up 168.95% in 2023, down 24.87% in 2023.
• Tracing TYRA's Total Current Liabilities over 5 years: stood at $5.7 million in 2022, then soared by 168.95% to $15.3 million in 2023, then slipped by 4.82% to $14.6 million in 2024, then rose by 23.98% to $18.1 million in 2025, then rose by 6.42% to $19.3 million in 2026.
• The last three Total Current Liabilities figures came in at $19.3 million (Q1 2026), $18.1 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.